Greenleaf Trust’s Viatris VTRS Stock Holding History
Bought
Maintained
Sold
Other funds holding VTRS
ACM
WCM
TIM
QAM
PCM
SIS
Greenleaf Trust's VTRS Position: Q2 2026 in Review
Greenleaf Trust reduced its Viatris (VTRS) stake by 1% in Q2 2026, selling an estimated $5.91K and leaving 36,589 shares worth $581K. The position accounts for 0.01% of the portfolio, ranked #478.
Greenleaf Trust first reported a position in VTRS in Q2 2020 and has held it in 25 quarters since. The position peaked at $881K in Q4 2020. 189 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.
- Greenleaf Trust held 36,589 shares of Viatris worth $581K as of Q2 2026.
- Greenleaf Trust sold 381 Viatris shares in Q2 2026, an estimated $5.91K.
- Viatris made up 0.01% of Greenleaf Trust's portfolio in Q2 2026, its #478 holding.
- Greenleaf Trust first reported a position in Viatris in Q2 2020 and has held it in 25 quarters since.
- Greenleaf Trust's Viatris position peaked at $881K in Q4 2020.
- 189 funds tracked by Wall St. Rank held Viatris as of Q2 2026.
Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.